BlackRock Fund Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $7.82M | Buy |
446,293
+58,678
| +15% | +$1.03M | ﹤0.01% | 2710 |
|
|
2016
Q3 | $9.22M | Buy |
387,615
+26,272
| +7% | +$625K | ﹤0.01% | 2526 |
|
|
2016
Q2 | $5.78M | Buy |
361,343
+6,082
| +2% | +$97.3K | ﹤0.01% | 2708 |
|
|
2016
Q1 | $7.43M | Sell |
355,261
-20,723
| -6% | -$433K | ﹤0.01% | 2521 |
|
|
2015
Q4 | $10.2M | Buy |
375,984
+19,555
| +5% | +$528K | ﹤0.01% | 2437 |
|
|
2015
Q3 | $9.91M | Buy |
356,429
+53,455
| +18% | +$1.49M | ﹤0.01% | 2374 |
|
|
2015
Q2 | $7.43M | Buy |
302,974
+272,612
| +898% | +$6.68M | ﹤0.01% | 2676 |
|
|
2015
Q1 | $556K | Sell |
30,362
-2,064
| -6% | -$37.8K | ﹤0.01% | 3248 |
|
|
2014
Q4 | $598K | Buy |
32,426
+5,333
| +20% | +$98.4K | ﹤0.01% | 3247 |
|
|
2014
Q3 | $260K | Buy |
+27,093
| New | +$260K | ﹤0.01% | 3382 |
|